Correspondence

Taylor AT. Catatonia: a review of a behavioural neurological syndrome. Neuropsychiatry, Neuropsychology, and Behavioural Neurology 1990; 3:48–72.

Regestein QR Alpert JS Reich P. Sudden catatonic stupor with disastrous outcome. Journal of the American Medical Association 1977; 238:618–620.

Mahendra B. Editorial: Where have all the catatonics gone? Psychological Medicine 1981; 11:669–671.

Abrams R Taylor MA. Catatonia: Prediction of response to somatic treatments. American Journal of Psychiatry 1977; 134:78–80.

Rosebush PI Hildebrand AM Furlong BG Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. Journal of Clinical Psychiatry 1990; 51:357–362.

McEvoy JP Lohr JB. Diazepam for catatonia. American Journal of Psychiatry 1984; 141:284–285.

Greenfeld D Conrad C Kincare P Bowers MB. Treatment of catatonia with low-dose lorazepam. American Journal of Psychiatry 1987; 144:1224–1225.

Gelenberg AJ Mandel MR. Catatonic reaction to high-potency neuroleptic drugs. Archives of General Psychiatry 1977; 34:947–950.

Fink M Taylor MA. Catatonia: a separate category in DSM-IV. Integrative Psychiatry 1991; 7:2–10.

Bowlby J. Attachment (Vol. 1). Middlesex, UK: Pelican, 1971.

Meares R. The persecutory therapist in the pursuit of intimacy. Melbourne, Vic.: Nelson, 1977.

Rogeness GA Javors MA Pliszka SR. Neurochemistry and child and adolescent psychiatry. Journal of the American Academy of Child and Adolescent Psychiatry 1992; 31:765–781.

Salkovskis PM Atha C Storer D. Cognitive behavioural problem solving in the treatment of patients who repeatedly attempt suicide: a controlled trial. British Journal of Psychiatry 1990; 157:871–876.

House A Owens D Storer D. Psycho-social intervention following attempted suicide: is there a case for better services? International Review of Psychiatry 1992; 4:15–22.

Gunnell D Frankel S. Prevention of suicide: aspirations and evidence. British Medical Journal 1994; 308:1227–1233.

Lipinski JF Mallya G Zimmerman P Pope HG. Fluoxetine-induced akathisia: Clinical and theoretical implications. Journal of Clinical Psychiatry 1989; 50:339–342.

Meltzer HY Matsubara S Lee JC. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin-2 pKi values. Journal of Pharmacology and Experimental Therapeutics 1989; 251:238–246.

Bernick C. Methysergide-induced akathisia. Clinical Neuropharmacology 1988; 11:87–89.

Kramer MS di Johnson C Davis P L-tryptophan in neuroleptic-induced akathisia. Biological Psychiatry 1990; 27:671–672.

Ugedo L Grenhoff J Svensson TH. Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition. Psychopharmacology 1989; 98:45–50.

Blandina P Goldfarb J Green JP. Activation of a 5-HT3 receptor releases dopamine from rat striatal slice. European Journal of Pharmacology 1988; 155:349–350.

Waddington JL. Schizophrenia, affective psychoses and other disorders treated with neuroleptic drugs: The enigma of tardive dyskinesia, its neurobiological determinants and the conflict of paradigms. Intenational Review of Neuroscience 1989; 31:297–353.

Casey DE. Spontaneous and tardive dyskinesia: Clinical and laboratory studies. Journal of Clinical Psychiatry 1985; 46:42–47.

Ayd FJ. A survey of drug-induced extrapyramidal reactions. Journal of the American Medical Association 1961; 175:1054–1060.

Sachdev P. Depression-dependent exacerbation of tardive dyskinesia. British Journal of Psychiatry 1989; 155:253–255.

Reynolds GP Brown JE McCall JC MacKay AVP. Dopamine receptor abnormalities in the striatum and pallidum in tardive dyskinesia: a post mortem study. Journal of Neural Transmission 1992; 87:225–230.

Lewander T Westerbergh S-E Morrison D. Clinical profile of remoxipride — a combined analysis of a comparative double blind, multicentre trial programme. Acta Psychiatrica Scandinavica 1990; 82:92–98.

Arya DK Szabadie E. Dyskinesia associated with fluvoxamine. (Letter) Journal of Clinical Psychopharmacology 1993; 13:365–366.

Mander AG McCausland B Workman B Flamer H Christophidis N. Fluoxetine induced dyskinesia. Australian and New Zealand Journal of Psychiatry 1994; 28:328–330.

Hunter E. Aboriginal suicides in custody: A view from the Kimberley, Australian and New Zealand Journal of Psychiatry 1988; 22:273–282.

Hunter E. On Gordian knots and nooses: Aboriginal suicide in the Kimberley. Australian and New Zealand Journal of Psychiatry 1988; 22:264–271.

Meggitt MJ. Desert people: A study of the Walpiri Aborigines of Central Australia. Sydney: Angus and Robertson, 1962.

Elkin AP. The Australian Aborigines: How to understand them. Sydney: Angus and Robertson, 1945.

Hart CWM Pilling AR Goodale JC. The Tiwi of North Australia. 3rd edition New York: Holt, Rinehart and Winston, 1988.

Eastwell H. The low risk of suicide amongst the Yolngu of the Northern Territory: the traditional Aboriginal pattern. Medical Journal of Australia 1988; 148:338–340.

Jones I de L Horne DJ Diagnosis of psychiatric illness among tribal Aborigines. Medical Journal of Australia 1972; 1:345–349.